Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has not only distressed medical services but also caused economic upheavals, marking urgent the need for effective therapeutics. The experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiou, Wei-Chung, Hsu, Meng-Shiuan, Chen, Yun-Ti, Yang, Jinn-Moon, Tsay, Yeou-Guang, Huang, Hsiu-Chen, Huang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808739/
https://www.ncbi.nlm.nih.gov/pubmed/33430659
http://dx.doi.org/10.1080/14756366.2020.1850710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808739/
https://www.ncbi.nlm.nih.gov/pubmed/33430659
http://dx.doi.org/10.1080/14756366.2020.1850710

Ejemplares similares